TE
$21.09
-0.75
(-3.43%)
As of Oct 22, 2026, 9:29 PM EDT · cached
Price history
Tectonic Therapeutic Inc (TECX) is trading down at $21.09 (-3.43%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Tectonic Therapeutic Inc net income history (FY2017–FY2025)
Net income
| FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Operating income | −$18.4M | −$46.2M | −$75.8M | −$120.2M | −$118.8M | −$105.4M | −$44.6M | −$58.0M | −$84.0M |
| Net income | −$18.6M | −$46.4M | −$73.0M | −$119.7M | −$119.1M | −$105.9M | −$42.8M | −$58.0M | −$74.2M |
| EPS (diluted) | −$8.38 | −$3.62 | −$2.66 | −$3.31 | −$2.78 | −$2.42 | −$33.76 | −$6.83 | −$4.05 |
| Balance sheet | |||||||||
| Cash and equivalents | $5.96M | $126.3M | $187.0M | $259.7M | $189.6M | $92.6M | $28.8M | $141.2M | $253.8M |
| Total assets | $7.02M | $133.5M | $200.5M | $271.2M | $203.8M | $103.9M | $39.4M | $152.9M | $261.0M |
| Total liabilities | $3.66M | $11.3M | $14.5M | $16.9M | $34.4M | $28.6M | $43.4M | $12.1M | $9.71M |
| Long-term debt | — | — | — | — | $15.0M | $15.0M | — | — | — |
| Shareholders' equity | −$23.1M | $122.2M | $186.0M | $254.3M | $169.5M | −$45.7M | −$84.6M | $140.8M | $251.3M |
| Cash flow | |||||||||
| Operating cash flow | −$16.4M | −$37.6M | −$67.7M | −$98.8M | −$98.0M | −$97.2M | −$40.7M | −$59.1M | −$60.1M |
| Capital expenditure | $383.0K | $1.83M | $1.58M | $1.18M | $2.46M | $267.0K | $279.0K | $156.0K | $208.0K |
| Free cash flow | −$16.8M | −$39.5M | −$69.3M | −$100.0M | −$100.5M | −$97.5M | −$41.0M | −$59.2M | −$60.3M |
Net income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$19.6M | −$14.0M | −$18.3M | −$22.3M | −$21.9M | −$21.5M | −$27.3M | −$24.2M |
| Net income | −$17.7M | −$12.4M | −$15.9M | −$20.0M | −$19.0M | −$19.2M | −$25.2M | −$22.3M |
| EPS (diluted) | −$1.20 | $9.68 | −$0.93 | −$1.07 | −$1.02 | −$1.03 | −$1.34 | −$1.18 |
| Balance sheet | ||||||||
| Cash and equivalents | $159.1M | $141.2M | $306.2M | $287.4M | $268.4M | $253.8M | $236.9M | $227.1M |
| Total assets | $168.7M | $152.9M | $314.8M | $295.3M | $277.0M | $261.0M | $246.6M | $237.0M |
| Total liabilities | $18.4M | $12.1M | $13.8M | $11.5M | $9.47M | $9.71M | $16.2M | $13.2M |
| Shareholders' equity | $150.4M | $140.8M | $301.0M | $283.8M | $267.5M | $251.3M | $230.4M | $223.8M |
| Cash flow | ||||||||
| Operating cash flow | −$19.6M | −$16.8M | −$13.1M | −$14.7M | −$17.8M | −$14.5M | −$18.4M | −$21.5M |
| Capital expenditure | $153.0K | $3.00K | $27.0K | $0 | $181.0K | $0 | $19.0K | $79.0K |
| Free cash flow | −$19.8M | −$16.8M | −$13.1M | −$14.7M | −$18.0M | −$14.5M | −$18.4M | −$21.5M |
From Tectonic Therapeutic Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Tectonic Therapeutic Inc
- Headquarters
- Watertown, Massachusetts From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International